BioScience Health Innovations Files 8-K
Ticker: BHIC · Form: 8-K · Filed: Oct 16, 2025 · CIK: 1784440
| Field | Detail |
|---|---|
| Company | Bioscience Health Innovations, Inc. (BHIC) |
| Form Type | 8-K |
| Filed Date | Oct 16, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
Related Tickers: BHIC
TL;DR
BHIC filed an 8-K for corporate governance updates and shareholder votes as of Sept 10, 2025.
AI Summary
BioScience Health Innovations, Inc. filed an 8-K on October 16, 2025, reporting events as of September 10, 2025. The filing primarily concerns amendments to its Articles of Incorporation or Bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company, formerly known as Nowtransit Inc., is incorporated in Nevada and has its principal executive offices in Salt Lake City, UT.
Why It Matters
This 8-K filing indicates significant corporate actions, including potential changes to the company's governing documents and shareholder votes, which could impact the company's structure and future direction.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain immediate negative financial or operational news.
Key Players & Entities
- BioScience Health Innovations, Inc. (company) — Registrant
- Nowtransit Inc. (company) — Former company name
- September 10, 2025 (date) — Date of earliest event reported
- October 16, 2025 (date) — Date of report
- Nevada (jurisdiction) — State of Incorporation
- Salt Lake City, UT (location) — Principal Executive Offices
FAQ
What specific amendments were made to the Articles of Incorporation or Bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the excerpt. Further review of the attached exhibits would be necessary.
What matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not detailed in the provided text. The exhibits would contain this information.
What financial statements and exhibits are included with this filing?
The filing lists 'Financial Statements and Exhibits' as an item information, indicating their inclusion, but the specific content of these exhibits is not detailed in the excerpt.
When was BioScience Health Innovations, Inc. formerly known as Nowtransit Inc.?
The company's name was changed from Nowtransit Inc. on August 2, 2019.
What is the principal business address of BioScience Health Innovations, Inc.?
The principal executive offices are located at 2722 S West Temple, Salt Lake City, UT 84115.
Filing Stats: 558 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2025-10-16 15:47:05
Filing Documents
- bhic8k101625.htm (8-K) — 26KB
- bhicex3-1.htm (EX-3.1) — 2KB
- ex3-1_001.jpg (GRAPHIC) — 262KB
- ex3-1_002.jpg (GRAPHIC) — 468KB
- ex3-1_003.jpg (GRAPHIC) — 375KB
- ex3-1_004.jpg (GRAPHIC) — 56KB
- ex3-1_005.jpg (GRAPHIC) — 245KB
- 0001185185-25-001456.txt ( ) — 2127KB
- bhic-20250910.xsd (EX-101.SCH) — 3KB
- bhic-20250910_lab.xml (EX-101.LAB) — 34KB
- bhic-20250910_pre.xml (EX-101.PRE) — 22KB
- bhic8k101625_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BioScience Health Innovations, Inc. a Nevada corporation Date: October 16, 2025 By: /s/ Darren Lopez Name: Darren Lopez Title: Chief Executive Officer 2